Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Thatcher

Showing results (161-170 of 289) with videos related to

Pageof 29
Sort By:
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomitingH Anderson, N Thatcher, A Howell, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1993
The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB studyJ A Hadfield, A T McGown, M J Dawson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesotheliomaS C White, H Anderson, G C Jayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancerP J Woll, J Hodgetts, L Lomax, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|April 1, 1971
Massive proteinuria after renal transplantation. A case reportJ B Ackermann, G N Thatcher, C J Uys, et al.
International Journal of Cancer|January 2, 1992
Haemopoietic cell kinetics in humans treated with rGM-CSFB I Lord, H Gurney, J Chang, et al.
British Journal of Cancer|June 1, 1990
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibodyH Dazzi, P S Hasleton, N Thatcher, et al.
British Journal of Cancer|December 1, 1988
The value of tumour markers in lung cancerS A Gomm, B G Keevil, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
British Journal of Cancer|April 1, 1979
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in manH H Wan, N Thatcher, P W Mullen, et al.
Pageof 29

Showing results (161-170 of 289) with videos related to

Sort By:
Pageof 29
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Tropisetron compared with a metoclopramide-based regimen in the prevention of chemotherapy-induced nausea and vomitingH Anderson, N Thatcher, A Howell, et al.
Journal of Pharmaceutical and Biomedical Analysis|August 1, 1993
The suitability of carboplatin solutions for 14-day continuous infusion by ambulatory pump: an HPLC-dynamic FAB studyJ A Hadfield, A T McGown, M J Dawson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Randomised phase II study of cisplatin-etoposide versus infusional carboplatin in advanced non-small-cell lung cancer and mesotheliomaS C White, H Anderson, G C Jayson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
Can cytotoxic dose-intensity be increased by using granulocyte colony-stimulating factor? A randomized controlled trial of lenograstim in small-cell lung cancerP J Woll, J Hodgetts, L Lomax, et al.
South African Journal of Surgery. Suid-Afrikaanse Tydskrif Vir Chirurgie|April 1, 1971
Massive proteinuria after renal transplantation. A case reportJ B Ackermann, G N Thatcher, C J Uys, et al.
International Journal of Cancer|January 2, 1992
Haemopoietic cell kinetics in humans treated with rGM-CSFB I Lord, H Gurney, J Chang, et al.
British Journal of Cancer|June 1, 1990
Malignant pleural mesothelioma and epidermal growth factor receptor (EGF-R). Relationship of EGF-R with histology and survival using fixed paraffin embedded tissue and the F4, monoclonal antibodyH Dazzi, P S Hasleton, N Thatcher, et al.
British Journal of Cancer|December 1, 1988
The value of tumour markers in lung cancerS A Gomm, B G Keevil, N Thatcher, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer--a phase I toxicity study and pharmacokinetic analysisJ Prendiville, N Thatcher, M Lind, et al.
British Journal of Cancer|April 1, 1979
Lack of effect of immunotherapy with BCG and Corynebacterium parvum on hepatic drug hydroxylation in manH H Wan, N Thatcher, P W Mullen, et al.
Pageof 29